Search

everythinglearnresearchcommunity

for

Search:↓

Hair color production is closely linked to the active growth phase of hair in mice and may also influence hair growth itself.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

Toll-like receptors are important for wound healing, but can slow it down in diabetic wounds.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Testosterone may slow down wound healing and increase inflammation.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Chemokine signaling is important for hair development.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Hair loss requires customized treatments based on its various causes and types.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Three drugs change mice's alcohol drinking patterns by affecting GABAA receptors.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.